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Abstract
Introduction: The human papillomavirus (HPV) is a prevalent 
viral infection in the sexually active population, which can be 
oncogenic and non-oncogenic. Educational efforts by health 
professionals, aimed at adolescents and their parents, help 
decision-making on human papillomavirus vaccination, 
benefiting the implantation process and vaccine coverage. 
Objective: To describe the data collection constructs 
about knowledge and acceptability of HPV vaccine among 
adolescents, parents and health professionals.
Methods: Study of construct elaboration based on an 
empirical review of the literature with a qualitative focus on 
PubMed database, from 2007 to 2014, using the following 
keywords: Papillomaviridae AND Papillomavirus Vaccines 
AND Knowledge AND Community Health Services. A total of 
31 questions were divided into six categories. In the internal 
validation, the final construct was applied in 390 subjects 
(adolescents, parents/guardians and health professionals) 
in the period of 2014. The proportion of assertive responses 
and respective 95% confidence interval (CI) were used to 
describe each question. 
Results: Three articles on the subject were found in 
the databases consulted that served as the basis for 
the elaboration of the questionnaire. There was a lower 
proportion of correct answers among adolescents about 
knowledge of HPV. Adolescents, parents, and carers showed 
a low proportion of correctness about the safety and efficacy 
of the vaccine. The three groups did not show any barriers to 
vaccine acceptability.  
Conclusion: The instrument was adequate to measure 
knowledge about HPV, its repercussions and its vaccine 
among adolescents, parents/guardians and health 
professionals, as well as measuring the acceptability of the 
human papillomavirus vaccine.
Keywords: HPV, papillomavirus vaccines, knowledge, 
adolescent, parents, health-care professional, surveys and 
questionnaires.
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Human papillomavirus (HPV) is a prevalent viral 
infection in the sexually active population, which can be 
oncogenic and non-oncogenic. The most cited oncogenic 
types are the 16 and 18 related to cancers of the uterus, 
anus, penis, vagina, mouth, among others. Non-oncogenes 
(6 and 11) have repercussions on women’s health, such as 
anogenital warts1,2. 
Cervical cancer affects women with an incidence 
of 16,340 cases in Brazil in 2016. This proportion of 
approximately 15.85 cases per 100,000 women represents a 
public health problem.3 The quadrivalent vaccine for HPV 
(6,11,16 and 18) is considered to be one of the strategies 
to reduce cervical cancer2,3, with protection of between 
80–100% vaccinates for anogenital warts and 60–80% in 
reducing new cases of pre-malignant lesions2,4. 
In Brazil, since 2014, the vaccine has been adopted 
in the National Immunization Program (PNI), targeting 
female adolescents from 9 to 13 years old5. The process 
of implantation and adequate vaccination coverage 
depends on the population’s knowledge about HPV and its 
repercussions on health, as well as an integrated approach 
among adolescents, parents and health professionals6,7.
Kwan et al.8 and Kornfeld et al.9 provide information 
on barriers to acceptance, knowledge gaps and public 
opinion on HPV and its vaccine through collection tools 
on the subject. In Brazil, Figueroa-Downing et al.10 and 
Osis et al.11 used a collection tool developed to describe the 
knowledge and attitudes of health professionals10 and the 
lay population11.
Collection instruments elaborated for situational 
analysis, although not generalizable, are exploratory in 
the sense of providing knowledge about a certain theme. 
The creation of a construct through descriptive research 
facilitates the operation of data collection and the use of the 
same data for analysis and value judgment12. In addition, the 
search for an HPV-based construct and its vaccine allows us 
to characterize the acceptance status of the population as 
well as the parents’ admissibility in deciding to vaccinate 
their children. 
Thus, the objective of this research is to describe the 
construct of data collection on knowledge and acceptability 
of HPV vaccine among adolescents, parents and health 
professionals. 
 INTRODUCTION
It is an instrument elaborated according to the criteria 
of validity of the construct with qualitative approach13,14 
(Figure 1):
Encounter between evidence13,14  
This is a process of organization by theme in the 
results of the selected articles and a review of the themes 
and issues between researchers regarding the  identification 
of relevant conclusions, contributing to the construction of 
the instrument on the knowledge of HPV and its vaccine.
Identification of the thematic
Organization by themes identified in the results of 
the selected articles, are shown in Table 1.
Review of report by researchers
A questionnaire was composed of 24 questions 
related to the knowledge and acceptability of HPV and 
its vaccine. The instrument was presented for consensus 
among specialists to complement and suggest changes.
The questionnaire was prepared and adapted 
four times before the definitive model was formulated. 
After consensus among experts, the questionnaire had 26 
questions. Abbreviations were withdrawn. It was decided to 
put ‘no response’ on issues aimed at women with a history 
of cervical cancer and health professionals, rather than as 
a “no-holds” or “no opinion” answers. Three questions 
were raised about vaccine safety, the source of knowledge 
about the HPV vaccine, and whether the subject had already 
received the vaccine. 
Specifically for health professionals, two questions 
were raised: whether patients living with human 
immunodeficiency virus (HIV) can be vaccinated and 
whether the vaccine is safe for pregnant women. The aim 
was to obtain a self-administered instrument. 
The final instrument for data collection (Figure 2) 
was composed of 31 questions divided into six categories: 
1) knowledge about HPV (7 questions); 2) knowledge about 
 METHODS
Figure 1: Flowchart for the construction of a construct with a 
qualitative focus on HPV knowledge, its repercussions and 
acceptability of the vaccine, following validity criteria
Use of sources of evidence 
An empirical literature review was carried out in the 
PubMed database from 2007 to 2014, with the following 
descriptors present in the MEsH terms: Papillomaviridae 
AND Papillomavirus Vaccines AND Knowledge AND 
Community Health Services. The inclusion criteria were: 
original articles on HPV and quadrivalent vaccine, as well 
as approach to construction and/or instrument use with 
questions about knowledge of HPV and its vaccine. Review 
articles, bivalent and non-validated HPV vaccine articles 
were excluded.  
The selection method was reading the title and 
abstract. At the end of the selection, the articles used and 
subsidized to the preparation of an instrument on the 
knowledge of HPV, the vaccine and its acceptance among 
adolescents, parents and/or carers and health professionals.
- Theoretical framework with literature review 
- Literature review, in the PUBMED database, 
from 2007 to 2014, with the descriptors: 
Papillomaviridae AND Papillomavirus Vaccines 
AND knowledge AND Community Health Services
Organization by topics identified in the results 
of selected articles;
Thematic review and questions among 
researchers
Verification among the interviewees 
(adolescents, parents/guardians and health 
professionals) with writing and data analysis
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Identification
Age:_____________  Birth Date:____/____/____
State:________________________________________________________________ 
City:____________________
Neighbourhood:________________________________________________
Sex: (  ) F (  ) M Marital status:  _____________________  Children:   (   )Yes     (   )No    (   )No of children
Profession: ___________________________________________  (   )yes, I am a health professional
Family income:  (   )< 2 minimum wage    (   )2 – 4 minimum wages    (   )4 – 10 minimum wages
                             (   )> 10 minimum wages     (   )do not know
Schooling:       (   )Illiterate (   )Elementary school   (   )High school  
(   ) Incomplete higher education   - which course: __________________
(   ) Complete higher education   - which course: ____________________
Domain 1: Knowledge about HPV
1. Do you know what HPV is? (  )no  (  )yes  (  )not sure
2. Is HPV a virus? (  )no (  )yes  (  )not sure
3. Is HPV a sexually transmitted disease? (  )no (  )yes  (  )not sure
4. Can HPV cause cervical cancer? (  )no (  )yes  (  )not sure
5. Can HPV cause changes in the Pap (screening for cervical cancer)? (  ) no  (  ) yes  (  ) not sure
6. Is cervical cancer a major cause of cancer in women? (  )no (  )yes (  )not sure
7. Can smoking increase the risk of cervical cancer? (  )no (  )yes (  )not sure
Domain 2: Knowledge about HPV vaccine
8. Does the HPV vaccine prevent cervical cancer? (  )no  (  )yes (  )not sure
9. Should the HPV vaccine be given before the first sexual intercourse? (  )no  (  )yes  (  )not sure
10. Can the HPV vaccine be given to people who have had sex? (  )no  (  )yes (  )not sure
11. Can HPV vaccine be harmful to health? (  )no (  )yes  (  )not sure
12. Can the HPV vaccine cause HPV infection? (  )no  (  )yes  (  )not sure
13. Is the HPV vaccine provided by the Government? (  )no (  )yes  (  )not sure
14. Is the HPV vaccine part of the girls’ immunization record? (  )no (  )yes  (  )not sure
15. Where did you hear about the HPV vaccine? (  )School  (  )Friends (  )TV/radio  (  )Internet  (  )Health professional (  )Others_____
16. Are 3 doses required for complete vaccination? (  )no (  )yes  (  )not sure
17. Does the HPV vaccine lessen the chance of having genital warts? (  )no  (  )yes  (  )not sure
18. Does the HPV vaccine decrease the chance of having Pap (cervical cancer screening) changes? (  )no  (  )yes  (  )not sure
Domain 3: HPV Vaccine Barriers
19. Do you think the HPV vaccine would stimulate the onset of sexual life earlier? (  )no  (  )yes  (  )not sure
20. Do you think that after the HPV vaccine you still need to use a condom? (  )no  (  )yes  (  )not sure
21. Do you think that after the HPV vaccine you still need to have the pap (cervical cancer screening)? (  )no  (  )yes  (  )not sure
Domain 4: Acceptability of HPV vaccine
22. Do you know anyone who has already had the HPV vaccine? (  )no  (  )yes  (  )not sure  
23. Have you taken the HPV vaccine yet? (  )no  (  )yes/ If yes (  )public services (  )particular services   (  )not sure             
24. Would you recommend the HPV vaccine for a child, friend, or relative to take? (  )no  (  )yes  (  )not sure
Domain 5: Personal Background
Answer only if you are female
25. Have you ever had pap (cervical cancer screening)? (  )no  (  )yes   (  )not sure
26. Have you ever had cervical cancer? (  )no  (  )yes  (  )not sure
27. Have you ever had genital warts? (  )no  (  )yes  (  )not sure
Domain 6: Health professionals 
Answer if you are a health professional
28. Patients living with HIV can take the vaccine? (  )no  (  )yes  (  )not sure  
29. Am I confident to indicate HPV vaccination for patients? (  )no  (  )yes
30. Do I feel confident giving information about HPV to patients? (  )no  (  )yes
31. Can pregnant women take the vaccine? (  )no  (  )yes  (  )not sure
Figure 2: HPV vaccine knowledge and acceptability questionnaire
the HPV vaccine (11 questions); 3) vaccination barriers for 
HPV (3 questions); 4) acceptability of HPV vaccine (3 
questions); 5) personal history related to HPV infection in 
female subjects (3 questions); 6) specific knowledge issues 
addressed to health professionals (4 questions).
The response options for the instrument questions 
were: yes (S); no (N); not sure (NTC). In order to score the 
answers, a grouping of the questions by themes was done, 
assigning (0) to the non-correct and (1) to the correctness of 
each question. There was a reversal of scores in questions 
11, 12, 19 and 31. The proportion of correct responses and 
respective 95% confidence intervals (CIs) were used to 
describe the proportion of correctness for each question and 
the knowledge and acceptability of the HPV vaccine.
Internal validity 
Verification among the interviewees (adolescents, 
parents/guardians and health professionals) with writing 
and data analysis are shown in Tables 2, 3 and 4. 
61DOI: http://dx.doi.org/10.7322/jhgd.143856
Knowledge and acceptance of hpv vaccine among adolescents, parents and health professionals: construct development for collection and database composition         J Hum Growth Dev. 2018; 28(1):58-68
Table 1: Synthesis of studies based on the theoretical framework for the development of an instrument on knowledge 
and/or acceptability of HPV and/or its vaccination
Author/Year/Title Objective Study population Results Theme identified
Giambi et al. 2014
‘Exploration 
of reasons for 
non-vaccination 
against human 
papillomavirus in 
Italy’
Conduct research 
among sample 
of families of 
unvaccinated girls to 
explore barriers to 
vaccination in Italy
Parents/guardians 
of unvaccinated girls 
born between 1997 
or 1998 who were 
offered vaccination 
between 2008 
and 2010 in the 
immunization records 
of 143 health units 
were interviewed.
A total of 1,738 questionnaires were 
analysed. The main barriers were fear 
of adverse events (reported by 80% of 
families), lack of confidence in a new 
vaccine (76%), discordant information 
received from health professionals 
(65%), and scarce information on 
HPV vaccination.  Overall, 54% of 
families correctly answered questions 
that explore knowledge about HPV 
vaccination. Paediatricians/general 
practitioners and gynaecologists were 
considered the most reliable source 
of information by 79% and 61% of 
respondents, respectively. Among 
parents who discussed vaccination 
with a physician, 28% received 
discordant advice and 31% received a 
recommendation to accept vaccination.
Knowledge about 
HPV;
Barriers to 
acceptance.
Knowledge about 
HPV vaccine among 
lay people.
Knowledge about 
HPV vaccine among 
health professionals. 
Chun-Jing Fu et 
al. 2014
‘Knowledge, 
perceptions and 
acceptability of 
HPV vaccine 
among medical 
students in 
Chongqing, China’
To assess medical 
students’ knowledge 
about HPV and 
HPV-related 
diseases as well 
as their attitudes 
towards HPV 
vaccination
A total of 605 
undergraduate 
medical students from 
Chongqing Medical 
University in China, 
aged 18 to 26 years, 
were interviewed 
using a structured 
and pretested 
questionnaire on 
knowledge of HPV.
About 68.9% of medical students were 
female. Among respondents, 71.8% 
were willing to receive advise on HPV 
vaccination. Female students (OR: 2.69, 
95% CI: 1.53, 4.72) and students who 
wanted more education about HPV (OR: 
4.24; 95% CI: 1.67; 10, 8) were more 
willing to accept vaccination against 
HPV. Acceptance of HPV vaccination 
shows a direct association with 
knowledge about HPV.
Knowledge about 
HPV;
Acceptability of HPV 
vaccine;
Identification of 
female influence 
on knowledge and 
acceptance of the 
HPV vaccine.
Rosberger Z, et 
al. 2013
‘HPV Vaccine 
education: 
Improving the 
knowledge 
and attitude 
of community 
counsellors and 
educators”
Explore the effect of 
health education to 
provide information 
among educators 
and counsellors 
on knowledge, 
attitudes and beliefs 
about HPV and its 
vaccine.
A study of 37 female 
employees of a 
community health 
and social service 
agency in Montreal, 
Canada, aged 
25–59, participated 
in a health education 
workshop on HPV 
and HPV vaccine.
Improvements were observed in the 
accuracy of knowledge, confidence in 
being able to discuss HPV vaccination 
issues with parents, greater willingness 
to recommend the vaccine and a better 
understanding of potential barriers to 
vaccine absorption.
Acceptability of HPV 
vaccine;
Barriers to 
acceptance.
Specific knowledge 
about the vaccine. 
Cultural adaptation of the instrument
A total of 390 individuals were selected by 
convenience sample, of which 219 were adolescents (10 to 
19 years old)15, were parents or guardians (aged over 20 
years) and 27 were health professionals. The study was 
carried out at the Casa do Adolescente of Pinheiros, in the 
city of São Paulo, SES/SP, in January 2014, with approval 
by the Research Ethics Committee of the University of São 
Paulo (205/14). 
For cultural adaptation of the instrument, problems 
of comprehensibility of the domains were identified and 
then a satisfactory index of knowledge for each domain 
of 80% was stipulated. In the application of the construct, 
there were no restrictions regarding sexual activity, colour, 
education and socio-economic level. Individuals who 
needed the presence of a companion during the interview 
and who did not understand the Portuguese language were 
excluded from the study.
Statistical analysis
The data collected was tabulated using Microsoft 
Excel spreadsheets. Data were used to describe the data: 
absolute and relative frequencies and interval estimates 
(95% CI) of the ratio of correct answers. The absolute 
sampling error was 5%. The analyses were carried out in 
the Stata® 11.0 (Stata Corp., College Station, EUA).
 RESULTS
Three articles16-18 were found about the subject in 
the databases consulted. The applicability of the construct 
was observed in three distinct regions, one in Canada, one 
in China and one in Italy (Table 1). 
Regarding the application of the construct, 390 
participants were interviewed, 79.7% (n = 311) were 
males and 20.3% were (n = 79) females. The sample was 
made of 56.2% (n = 219) adolescents, 36.9% (n = 144) 
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parents and/guardians and health professionals 6.9% (n 
= 27). The questionnaire was applied during interviews, 
answered individually by the interviewees, in a calm and 
private environment.
After data collection, there was a moment of open 
discussion among researchers and interviewees about 
actions that could be taken regarding health promotion 
and counselling on HPV and its repercussions, as well as 
regarding HPV vaccine in population health.
Interviewees presented difficulties in understanding 
the confounding issues between HPV (human papilloma 
virus) and HIV (human immunodeficiency virus). There was 
also a need to exchange terms from the ‘cervical oncology 
colpocytology examination’ to ‘Pap’ (popular terminology), 
as well as using the colloquial term ‘Pap changes’ rather than 
the technical term ‘high or low intraepithelial neoplastic 
grade’ or ‘low- and high-grade intraepithelial lesion’.
In Table 2, regarding the perception about HPV 
knowledge and its repercussions on health, a lower 
proportion of correctness was identified, especially among 
adolescents, for the following questions: What is HPV?’ 
60.7% (CI 53.9, 67.2); ‘Is it a virus?’ 68.9% (IC 62.4, 75.0); 
‘Is it a sexually transmitted disease?’ 47.0% (CI 40.3, 53.9); 
‘Is it related to cervical cancer? 66.7% (CI 60.0; 72.9); ‘Can 
HPV cause changes in the Pap?’ 50.2% (CI 43.4; 57.0) and 
‘Is cervical cancer a major cancer in women?’ 64.4% (CI 57; 
7.70–7.7). Smoking was not perceived as a risk for cervical 
cancer among the interviewees, with 47.5% (CI 40.7; 54.3) 
of adolescents, 60.5% (CI 52.2; 68.5) of parents/guardians, 
59.3% (CI 38.8; 77.6) of health professionals. 
Table 3: Knowledge and perception on topics such as HPV, its repercussions, vaccine for HPV, São Paulo, Brazil, 2017
Knowledge about HPV vaccine Adolescents Parents and guardians Health professionals
Ratio (CI 95%)
Does the HPV vaccine prevent cervical cancer? 80,4 (77,5; 85,4) 88,4 (82,1; 93,1) 81,5 (61,9; 93,7)
Should the HPV vaccine be given before the first 
sexual intercourse?
65,8 (59,1; 72,0) 81,0 (73,7; 87,0) 88,9 (70,8; 97,6)
Can the HPV vaccine be given to people who 
have had sex?
52,1 (45,2; 58,8) 70,1 (62,0; 77,3) 70,4 (49,9; 86,2)
Can HPV vaccine be harmful to health? 10,0 (6,4; 14,8) 10,2 (5,8; 16,3) 100,0 (87,3; 100,0)
Can the HPV vaccine cause HPV infection? 44,7 (38,0; 51,6) 55,1 (46,7; 63,3) 70,4 (49,8; 86,2)
Does the Government provide the HPV vaccine? 63,9 (57,2; 70,3) 82,3 (75,2; 88,1) 81,5 (66,3; 93,7)
Is the HPV vaccine part of the girls' immunization 
record?
53,0 (46,1; 59,7) 69,4 (61,2; 76,7) 85,2 (66,3; 95,8)
Are 3 doses required for complete vaccination? 42,9 (36,3; 49,8) 57,8 (48,4; 65,9) 74,1 (53,7; 88,9)
Does the HPV vaccine lessen the chance of 
having genital warts?
32,4 (26,3; 39,1) 48,3 (40,0; 56,7) 74,1 (53,7; 88,9)
Does the HPV vaccine decrease the chance 
of having Pap (cervical cancer screening) 
changes?
22,4 (17,0; 28,5) 34,7 (27,0; 43,0) 51,8 (31,9; 71,3)
Ratio CI; Confidence interval 95%
Knowledge about what is HPV Adolescents Parents and guardians Health professionals
Ratio (CI 95%)
Do you know what HPV is? 60.7 (53.9; 67.2) 81.0 (73,7; 87,0) 92.6 (75.7; 99.1)
Is HPV a virus? 68.9 (62.4. 75.0) 81.6 (74,4; 87,5) 96.3 (81.0; 99.9)
Is HPV a sexually transmitted disease? 47.0 (40.3; 53.9) 65.3 (57.0; 73.0) 85.2 (66.3; 95.8)
Can HPV cause cervical cancer? 66.7 (60.0; 72.9) 87.1 (80.6; 92.0) 88.9 (70.8; 97.6)
Can HPV cause changes in the Pap test (cervical cancer 
screening)?
50.2 (43.4; 57.0) 75.5 (67.7; 82.2) 77.8 (57.7; 91.4)
Is cervical cancer a major cause of cancer in women? 64.4 (57.7; 70.7) 87.1 (80.6; 92.0) 85.2 (66.3; 95.8)
Can smoking increase the risk of cervical cancer? 47.5 (40.7; 54.3) 60.5 (52.2; 68.5) 59.3 (38.8; 77.6)
Ratio CI; Confidence interval 95%
Table 2: Knowledge about HPV and perception about topics such as HPV, its interactions with the human host, HPV vaccine, São Paulo- 
Brazil, 2017
In Table 3, the perception of knowledge about 
HPV vaccine as a form of cervical cancer prevention was 
shown to have a high level of correctness, with 80.4%(CI 
77.5; 85.4) for adolescents, 88.4% (CI 82.1; 93.1) for 
parents/guardians and 81.5% (CI 61.9; 93.7) for health 
professionals. The timing to be vaccinated had a lower 
proportion of correctness among adolescents, 65.8% (CI 
59.1; 72.0), also 52.1% (CI 45.2; 58.8) of them perceived 
that it was not necessary to be vaccinated before the 
beginning of sexual intercourse.
Adolescents and parents/guardians showed a lower 
proportion of correct responses 10.0% (CI 6.4; 14.8) and 
10.2% (CI 5.8; 16.3), respectively, on the vaccine being 
harmful to health. The proportion of wrong answers was 
higher among adolescents in the following questions: ‘Can 
the HPV vaccine cause HPV infection?’ 44.7% (CI 38.0; 
51.6); ‘Is the HPV vaccine provided by the government?’ 
63.9% (CI 57.2; 70.3)’, ‘Is the HPV vaccine part of the 
girls’ immunization record?’ 53.0% (CI 46.1; 59.7), ‘Are 3 
doses required for complete vaccination?’ 42.9% (CI 36.3; 
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 DISCUSSION
Table 4: Acceptability and female personal history related to HPV, São Paulo- Brazil, 2017
Domains Adolescents Parents and Guardians Health professionals
Ratio (CI 95%)
Acceptability
Do you know anyone who has already 
had the HPV vaccine?
49,3 (42,5; 56,1) 38,8 (30,9; 47,2) 55,6 (35,3; 74,5)
Have you taken the HPV vaccine yet? 19,6 (14,6; 25,5) 9,5 (5,3; 15,5) -
Would you recommend the HPV vaccine 
for your child, friend or relative to take?
78,5 (72,5; 83,8) 90,5 (84,5; 94,7) 81,5 (61,9; 93,7)
Female personal history
Have you ever had Pap (cervical cancer 
screening)?
-- 6,4 (2,8; 12,2) 5,2 (0,01; 26,0)
Have you ever had cervical cancer? -- 2,4 (0,04; 6,8) 5,2 (0,01; 26,0)
Have you ever had genital warts? -- 7,2 (0,3; 13,2) 5,2 (0,01; 26,0)
- Not applicable, outside the age range of vaccination.
--Not applicable, outside the age range of collection of oncology cytology of the cervix
49.8) and ‘Does the HPV vaccine decrease the chances of 
having genital warts?’ 32.4% (CI 26.3; 39.1). 
Adolescents, parents and health professionals had 
a low proportion of correct responses when questioned 
about the efficacy of the HPV vaccine in reducing 
precursor lesions of cervical cancer with 22.4% (CI 17.0; 
28.5), 34.7% (CI 27.0; 43.0) and 51, 8% (CI 31.9; 71.3), 
respectively.
In Table 4, the parents/guardians were identified 
as having fewer propensities for assertive responses 
regarding vaccine acceptance on the following questions: 
‘Do you know anyone who has ever had the HPV vaccine?’ 
38.8% (CI 30.9; 47.2) and ‘Have you received the HPV 
vaccine?’ 9.5% (CI 5.3; 15.5). They would recommend 
the vaccine for their own children, friend or relative in 
90.5% (CI 84.5; 94.7).  
The elaboration of an instrument for collecting data 
on HPV knowledge and acceptability of the vaccine based 
on an empirical review of the literature with a qualitative 
approach allows the analysis of the perception of the 
subject, the measurement of the knowledge about HPV, its 
repercussions and its vaccine among adolescents, parents/
guardians and health professionals, as well as measuring 
the acceptability of the vaccine.
Knowledge and acceptability research of the 
HPV vaccine aims to understand the cultural aspects and 
knowledge of the population about vaccination for better 
adherence and territorial vaccine coverage.
The results of the qualitative review of the literature 
identified articles that address the use of health tools to 
explore the themes ‘HPV’ and ‘HPV vaccine’ in different 
populations. Giambi et al.16 developed a questionnaire 
containing 23 items, divided into 9 categories: 
demographic and behavioural information; vaccination; 
barriers and reasons for non-vaccination; knowledge of 
HPV; source of information about HPV; perception of risk 
that their daughter could contract HPV; intention of future 
vaccination; counselling of health professionals consulted 
on HPV vaccination. In the same study, 1738 relatives of 
unvaccinated girls were interviewed to explore barriers to 
vaccination in Italy.
Rosberger et al.18 investigated the effect of a 
workshop on HPV and its vaccine among employees of a 
community health and social service agency in Montreal, 
Canada, where participants responded to 20 items that 
measure HPV knowledge before and after the workshop. 
The questionnaire contained topics on confidence in the 
ability to provide accurate information to parents and 
on the HPV vaccine recommendation for daughters and 
nieces, as well as items assessing beliefs about possible 
barriers to HPV vaccine.
Fu et al.17 evaluated medical students’ knowledge 
about HPV and HPV-related diseases, as well as the 
intention of vaccinating this population through an 
instrument addressing socio-demographic information, 
such as age, gender, ethnicity and degree of knowledge 
about HPV, cervical cancer, genital warts and HPV 
vaccines and their own perceptions on the theme.
The synthesis of the three articles identified from 
the descriptors allowed the definition of the categorizing 
topics to be approached, such as knowledge about HPV, 
about the HPV vaccine, barriers to vaccine acceptance and 
specific awareness among health professionals.
Giambi et al.16 emphasize the importance of 
exploring vaccination acceptance barriers in the families 
of unvaccinated Italian girls, such as fear of adverse 
events and vaccine safety in developing HPV-induced 
lesions. Rosberger et al.18 demonstrated that health 
education among health professionals with specific topics 
being covered regarding the HPV vaccine brought greater 
reliability in providing information and recommending 
the vaccine among professionals.
Knowledge about HPV, cervical cancer, genital 
warts and HPV vaccines, as well as perceptions of 
vaccination were evaluated by Fu et al.17.  In this study, 
the influence of the female sex on the knowledge and 
acceptance of the HPV vaccine was shown to be higher 
in the intention to vaccinate. All of those related health 
factors vary in the general population according to sex, 
age and educational level11,19,20.
64DOI: http://dx.doi.org/10.7322/jhgd.143856
J Hum Growth Dev. 2018; 28(1):58-68         Knowledge and acceptance of hpv vaccine among adolescents, parents and health professionals: construct development for collection and database composition
The collected and analysed collection instrument 
indicates a lower proportion of correct answers in the 
categories ‘HPV knowledge’ and ‘vaccine acceptability’ 
among the adolescents interviewed, followed by parents/
guardians and health professionals, being “knowledge 
gaps about HPV and its repercussions on health” health 
education topics to be addressed in each population.
In turn, adolescence is a period marked by 
biopsychosocial changes and emotional instability, which 
arouses in adolescents the desire to experience new 
experiences, often in a rash manner, such as unprotected 
sex. Due to this condition of development and exposure, 
they are vulnerable, becoming exposed to, for example, 
sexually transmitted diseases, thus requiring physical, 
psychological and social protection from the family, 
school and community21,22.
Knowledge about HPV was considered low among 
adolescents from several countries23,24, a common finding 
evidenced by the construct. This finding corroborates 
the need to reaffirm the importance of sex education 
programmes and the provision of information on the 
disease and vaccine.   
The construct, through questions related to the 
subject ‘knowledge of HPV and its clinical repercussions’, 
showed a lower propensity to learn about the relation 
between smoking and the risk of developing cervical 
cancer. Tobacco is the second most commonly used drug 
among young people in the world25, so discouraging them 
from use is a public health challenge. 
In addition, joint actions of promotion and 
prevention combining the themes of HPV and smoking, 
especially among adolescents, should be encouraged, 
since tobacco is also a cofactor in the development of 
cervical cancer and interferes with the immunity of young 
women26. 
Adolescents perceived the vaccine to be a primary 
form of prevention of cervical cancer and saw the 
importance of administration prior to first sexual contact 
when questioned in the construct about the relationship 
between HPV, cervical cancer and sexual activity. 
Kilic et al.6 have identified that the motive and interest 
in receiving the vaccine is related to the protection 
against HPV and cervical cancer. However, Kwan et al.8 
demonstrated that a low knowledge and understanding 
about the prevention and disease process of HPV and the 
vaccine was paradoxically good for the acceptance of the 
vaccine process.
In Latin American reports, adolescents 
demonstrated an interest in the HPV vaccine, although 
they considered the vaccine to be new technology and 
lacked specific information about it. In addition, the 
acceptance of the vaccine was related to the age group 
and the presence of sexual activity27.
Acceptance barriers in the target population 
(adolescents)27 and refusal to vaccinate exist due to factors 
such as fear of experiencing pain during the application, 
fear of family disapproval, uncertainty about vaccine 
efficacy8,28. Lack of adequate information and myths 
regarding HPV infection can lead to the over-evaluation 
of the vaccine and affect the perception of the importance 
of surveillance against cervical cancer8.
The vaccine knowledge gap regarding its safety 
and its preventive action against precursor lesions and 
genital warts27 are perceptions identified by the construct 
among those adolescents interviewed.
The problem of vaccine acceptance should be 
viewed as a network with varying levels of complexity: 
social and racial inequality has a direct influence on many 
health issues and is not different29. Family support and 
a shared decision should always be preferred to simple 
government imposition24.
Parents’ knowledge about HPV and its 
repercussions on the health of adolescents, sons and 
daughters, is fundamental for the acceptance of the 
vaccine9. The decision of whether to be vaccinated or not 
is influenced by parents and family members, especially 
in the earliest target population6. Many parents are 
against vaccination for fear of possible side effects and 
there is therefore a lack of knowledge about the safety 
and positive impact of the vaccine on the health of their 
children9. 
After the introduction of the vaccine in national 
immunization programmes, studies have shown greater 
acceptability to the vaccine in other countries30,31. 
However, in British Columbia (Canada), even with public 
funding and vaccination in schools, 35% of parents 
decided not to vaccinate their daughters. The main 
reasons reported were concerns about vaccine safety, 
intent to wait until their daughter was older, and not 
having enough information about the vaccine32.
The construct (Figure 2) demonstrated that parents 
and carers are informed about the existence of the HPV 
vaccine and are in favour of its implementation and the 
government’s initiative to vaccinate their daughters. A 
regional study in our country observed that there were 
no difficulties in accepting the vaccine in our country33, 
which is corroborated bythe interviewees.
Knowledge about the viral origin of HPV and 
its involvement with cervical cancer, as well as it being 
sexually transmissible and causing changes in the cervical 
oncology cytology were themes identified through the 
elaborated construct. The postponement of vaccination 
is a vaccination barrier related to knowledge about the 
vaccine and HPV33, as well as knowledge gaps regarding 
HPV infections and their relation to cervical cancer34, and 
these have repercussions, such as postponing vaccination 
for their children. 
Another barrier to acceptance of common 
vaccination is the myth among parents that vaccination 
may lead to early or promiscuous sexual activity, 
increasing the number of sexual partners and also 
negatively affecting condom use35. Conversely, the 
parents interviewed (Tables 2 to 4) were accepting of 
the vaccine and showed no sign of believing the myths 
related to the early onset of sexual activity.  
The construct revealed doubts about the safety 
and efficacy of the HPV vaccine, especially among the 
parents interviewed in the study (Table 3). Albright et 
al.36 demonstrated similar doubts regarding the safety 
and efficacy of the vaccine, which was reflected in the 
decision of these parents to postpone the vaccination 
of their daughters until its effectiveness was proven. 
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Cheruvu et al.37 show that parents did not intend to 
vaccinate their daughters because of safety concerns and 
Figueroa-Downing et al.10 also found knowledge gaps 
related to vaccine safety in their study.
Regarding the efficacy of the vaccine on the health 
of the vaccinated, the construct enabled the identification 
of a lower propensity of correctness between the 
interviewed parents when asked about the reduction in 
the chance of acquiring genital warts and on the efficacy 
of the vaccine in reducing alterations caused by HPV in 
the examination screening of the cervix (pap). Health 
professionals in the McRee et al.38 study gave parents 
assurances that the HPV vaccine is safe and still claim to 
influence the parents’ decision about the vaccination of 
their children. 
Nunes et al.39 agree that the vaccine is highly 
effective for the prevention of specific viral serotypes 
(HPV 6, 11, 16 and 18), and Harper and Demars40 
evaluated and tested the efficacy of the vaccine for the 
prevention of HPV in this first vaccination decade. 
Thus, there is evidence in the literature of the 
benefits of the HPV vaccine. Health professionals need 
to be more proactive in recommending the HPV vaccine, 
instructing not only in informed decision-making 
but emphasizing its importance and the commitment 
to complete the series of vaccines required by the 
government, ensuring adequate vaccine coverage41.
The health professionals present a greater 
proportion of correctness in the related questions on the 
knowledge of HPV, about it being a sexually transmitted 
disease and having cervical cancer-related aetiology. 
Figueroa-Downing10 corroborates a similar proportion of 
correctness regarding HPV and its sexual transmission.
The relationship between the alterations found 
in cervical oncology cytology and HPV infection was a 
knowledge gap among the health professionals interviewed 
identified by the construct. Health professionals still did 
not relate smoking to cervical cancer, revealing doubts or 
issues needing to be clarified in health education training 
for professionals and that affect adolescent health.
Regarding the knowledge about the HPV vaccine, 
the interviewees revealed doubts about its efficacy 
against cervical cancer precursor lesions, the vaccine 
regimen and its safety. Studies demonstrate the efficacy 
of the vaccine in reducing low- and high-grade cervical 
lesions in countries that have adopted the vaccine as a 
primary form of prevention of cervical cancer for more 
than 5 years4,39,42. 
Health professionals recommend vaccination 
as a primary prevention of HPV43 and state that they 
offer the HPV vaccine as an optional immunization for 
adolescents38. This reinforces the importance of territorial 
studies and health professionals on the subject. The results 
demonstrate that the health professionals interviewed 
know that the vaccine is offered free of charge by the 
health system and is part of the national immunization 
programme. 
The health professionals oriented regarding the 
competence to indicate the vaccine and insurance in their 
concepts regarding efficacy and safety are guiding in this 
process of implantation of new means of prevention of 
condyloma acuminata, cervical cancer and among other 
repercussions caused by HPV, contributing to public 
health in the construction of preventive actions and 
strategies19,44.
Health professionals should be up to date with 
the nationally implemented programme and attentive to 
the knowledge gaps of parents and adolescents about 
HPV and its repercussions in order to guide them more 
effectively. They should also identify the acceptance 
barriers that exist in the health education regarding the 
HPV vaccine, demystifyi taboos in the population and 
contribute towards complete vaccine coverage7,20.
On the other hand, fears about vaccine safety and 
the information conveyed by some groups have impacted 
acceptability in some countries32,45,46,47. Because it is 
a recent vaccine, more follow-up studies are needed in 
the different countries following the introduction of 
vaccination. Policies and programmes need to be reviewed 
and re-evaluated as research results and monitoring data 
become available. 
Thus, in the qualitative approach, the 
methodological rules of empirical search of the literature 
are not fixed and totally defined, bringing a limitation to 
the study in terms of the systematization of the review. 
The elaboration of the construct through a qualitative 
review is flexible and particular with evolution throughout 
the research for a construct based on the interaction and 
analysis of the researchers13,14. 
The strengths of the present study are the novelty of 
the questionnaire, presenting a more accessible language 
(since a good part of the target audience is lay), with 
questions directed to parents, adolescents and specific to 
health professionals and females, as well as the ability 
to test the said research instrument, which may serve as 
a basis for future studies. A possible limitation can be 
attributed to the small number of participants, making it 
difficult to establish statistically significant differences 
between the subgroups.
The construct enables the identification of the 
knowledge and perception of topics such as HPV, its 
repercussions on women’s health and the acceptability 
of the vaccine by the target population as well as 
by the parents and health professionals. Finally, the 
construct enables the application of the data collection 
instrumenting diverse populations.  
The construct/instrument was adequate in 
assessing the knowledge about HPV, its repercussions 
and its vaccine among adolescents, parents/guardians 
and health professionals, as well as assessing the 
acceptability of the human papillomavirus vaccine. Thus 
it is an adequate instrument for the collection of data on 
the thematic knowledge and perception of topics such as 
HPV, its interaction with the human host, and the HPV 
vaccine.
 CONCLUSION
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Resumo
Introdução: O papilomavírus humano (HPV) é infecção viral prevalente na população sexualmente 
ativa, podendo ser oncogênico e não oncogênico. Esforços educacionais realizados por profissionais 
de saúde, voltados para adolescentes e seus pais auxiliam a tomada de decisão sobre a vacinação 
para o papilomavírus humano, beneficiando o processo de implantação e cobertura vacinal. 
Objetivo: Descrever constructo de coleta de dados sobre conhecimento e aceitabilidade da vacina 
para o HPV entre adolescentes, pais e profissionais de saúde. 
Método: Estudo de elaboração de constructo a partir de revisão de base empírica da literatura com 
enfoque qualitativo em base de dados do PubMed, no período de 2007 a 2014, com a utilização das 
palavras-chave: Papillomaviridae AND Papillomavirus Vaccines AND knowledge AND Community 
Health Services. Elaborou-se 31 questões divididas em seis categorias. Na validação interna foi aplicado 
o constructo final em 390 indivíduos (adolescentes, pais/responsáveis e profissionais de saúde) no 
período de 2014.  A proporção de acerto das respostas e respectivo intervalo de confiança de 95% 
foram utilizados para descrever cada questão. 
Resultados: Foram encontrados três artigos sobre a temática nas bases de dados consultadas que 
serviram como base para elaboração do questionário. Verificou-se menor proporção de acerto entre 
adolescentes sobre o conhecimento do HPV. Adolescentes, pais e responsáveis mostraram-se com 
baixa proporção de acerto sobre a segurança e eficácia da vacina. Os três grupos não mostraram 
barreiras de aceitabilidade à vacina.  
Conclusão: O instrumento mostrou-se adequado para mensurar o conhecimento sobre o HPV, suas 
repercussões e sua vacina entre os adolescentes, pais/responsáveis e profissionais de saúde, bem 
como sobre a aceitabilidade da vacina para o papilomavírus humano.
Palavras-chave: HPV, vacinas contra papilomavirus, conhecimento, adolescente, pais, profissional de 
saúde, inquéritos e questionários.
